1. Home
  2. FDBC vs NKTR Comparison

FDBC vs NKTR Comparison

Compare FDBC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FDBC
  • NKTR
  • Stock Information
  • Founded
  • FDBC 1902
  • NKTR 1990
  • Country
  • FDBC United States
  • NKTR United States
  • Employees
  • FDBC N/A
  • NKTR N/A
  • Industry
  • FDBC Major Banks
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FDBC Finance
  • NKTR Health Care
  • Exchange
  • FDBC Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • FDBC 246.3M
  • NKTR 238.7M
  • IPO Year
  • FDBC N/A
  • NKTR 1994
  • Fundamental
  • Price
  • FDBC $48.92
  • NKTR $1.32
  • Analyst Decision
  • FDBC
  • NKTR Buy
  • Analyst Count
  • FDBC 0
  • NKTR 4
  • Target Price
  • FDBC N/A
  • NKTR $2.50
  • AVG Volume (30 Days)
  • FDBC 8.4K
  • NKTR 988.9K
  • Earning Date
  • FDBC 10-23-2024
  • NKTR 11-05-2024
  • Dividend Yield
  • FDBC 3.11%
  • NKTR N/A
  • EPS Growth
  • FDBC N/A
  • NKTR N/A
  • EPS
  • FDBC 2.75
  • NKTR N/A
  • Revenue
  • FDBC $70,433,000.00
  • NKTR $93,157,000.00
  • Revenue This Year
  • FDBC N/A
  • NKTR N/A
  • Revenue Next Year
  • FDBC N/A
  • NKTR N/A
  • P/E Ratio
  • FDBC $17.82
  • NKTR N/A
  • Revenue Growth
  • FDBC N/A
  • NKTR 6.17
  • 52 Week Low
  • FDBC $41.10
  • NKTR $0.41
  • 52 Week High
  • FDBC $60.85
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • FDBC 46.33
  • NKTR 56.07
  • Support Level
  • FDBC $47.41
  • NKTR $1.11
  • Resistance Level
  • FDBC $50.23
  • NKTR $1.39
  • Average True Range (ATR)
  • FDBC 1.29
  • NKTR 0.09
  • MACD
  • FDBC -0.51
  • NKTR 0.01
  • Stochastic Oscillator
  • FDBC 18.69
  • NKTR 75.00

About FDBC Fidelity D & D Bancorp Inc.

Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: